Enfermedades Neurológicas
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies
The Lancet Neurology Volume 16, No. 5, p351–359, May 2017 Dr Daryl J Wile, Pankaj A Agarwal, DM, Prof Michael...
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease
Neurology Journal April 18, 2017 vol. 88 no. 16 1501-1511 Lynn Rochester, PhD, Brook Galna, PhD, Sue Lord, PhD, Alison J. Yarnall, MRCP, Rosie Morris, MSc, Gordon Duncan,...
Cerebral glucose metabolism and cognition in newly diagnosed Parkinson’s disease: ICICLE-PD study
Journal of Neurology, Neurosurgery & Psychiatry Volume 88, Issue 4 M J Firbank, A J Yarnall, R A Lawson, G W...
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults...
The Lancet Neurology Volume 16, No. 5, p377–389, May 2017 Prof Sandrine Andrieu, Sophie Guyonnet, PhD, Nicola Coley, PhD, Christelle...
Epileptic activity in Alzheimer’s disease: causes and clinical relevance
The Lancet Neurology Volume 16, No. 4, p311–322, April 2017 Dr Keith A Vossel, MD, Maria C Tartaglia, MD, Haakon B Nygaard,...
Lo más popular
- Mapa de Asociaciones de Familiares de personas con Alzheimer
- Ejercicios de estimulación cognitiva para personas con demencia
- Calidad de vida en pacientes adultos con epilepsia generalizada idiopática. Estudio EPILAK
- «Con los ojos de un niño» Cómic de Unidos Contra el Parkinson para explicar la enfermedad...
- Association Between Anatomical Location of Surgically Induced Lesions and Postoperative Se...
- Mapa de asociaciones de la Federación Española de Parkinson
- Celebrando la Navidad con una persona con Alzheimer